Cdc37 as a Co-chaperone to Hsp90

Area of Science:

• Molecular Biology
• Cellular Signaling
• Oncology

Background:

• The co-chaperone p50/Cdc37 is crucial for Hsp90 chaperone activity, particularly in regulating protein kinases.
• Cdc37 acts as a central hub, controlling the folding of many intracellular protein kinases and influencing numerous signaling networks.

Purpose of the Study:

• To highlight the multifaceted roles of Cdc37 in cellular processes, cancer, and aging.
• To explore Cdc37 as a potential therapeutic target in oncology and a factor in longevity.

Main Methods:

• Structural analysis of Hsp90-Cdc37-kinase complexes.
• Review of literature on Cdc37's involvement in signaling, carcinogenesis, and aging.

Main Results:

• Cdc37's interaction with Hsp90 governs protein kinase folding and signaling pathway regulation.
• Elevated Cdc37 expression in tumors, coupled with its control over multiple pathways, suggests potential for selective cancer targeting and robustness against resistance.
• Cdc37's involvement in protein aggregation, autophagy, and secretion via exosomes indicates broader roles in pathophysiology and aging.

Conclusions:

• Cdc37 is a critical regulator of protein kinases and cellular signaling, implicated in cancer development and progression.
• Its unique properties make Cdc37 an attractive therapeutic target for various cancers.
• Further research into Cdc37's role in aging, protein homeostasis, and autophagy may reveal its potential in longevity and age-related diseases.